New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents

Details for Australian Patent Application No. 2006239444 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Schulze, Volker; Prien, Olaf; Brittain, Dominic E.A.; Guenther, Judith; Eis, Knut; Wortmann, Lars; Siemeister, Gerhard; Eberspaecher, Uwe; Kosemund, Dirk

Agent Davies Collison Cave

Pub. Number AU-A-2006239444

PCT Pub. Number WO2006/114334

Priority 102005020105 25.04.05 DE

Filing date 24 April 2006

Wipo publication date 2 November 2006

International Classifications

C07D 277/20 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

15 November 2007 PCT application entered the National Phase

  PCT publication WO2006/114334 Priority application(s): WO2006/114334

1 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006239471-Vaccine

2006239443-New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents